NYSE:ABBV | Free Cash Flow | AbbVie Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$3.83B$265M$3.56B512.81%
2025-12-31$5.22B$329M$4.89B269.22%
2025-03-31$1.64B$235M$1.4B108.86%
2024-12-31$7.05B$291M$6.76B
2024-03-31$4.04B$193M$3.85B281.01%
2023-12-31$4.75B$205M$4.55B553.28%
2023-03-31$4.19B$175M$4.02B1681.17%
2022-12-31$7.43B$213M$7.22B291.75%
2022-03-31$4.91B$162M$4.75B105.70%
2021-12-31$5.08B$187M$4.89B120.87%
2021-03-31$4.88B$188M$4.69B131.97%
2020-12-31$4.85B$279M$4.58B12708.33%
2020-03-31$3.82B$125M$3.69B122.59%
2019-12-31$3.28B$163M$3.11B111.10%
2019-03-31$3.02B$107M$2.91B118.49%
2018-12-31$3.39B$123M$3.27B
2018-03-31$2.65B$119M$2.53B90.77%
2017-12-31$2.58B$182M$2.4B4619.23%
2017-03-31$2.1B$95M$2.01B117.30%
2016-12-31$1.54B$114M$1.43B102.59%
2016-03-31$2.13B$121M$2.01B148.23%
2015-12-31$1.96B$145M$1.82B119.84%
2015-03-31$1.59B$145M$1.44B
2014-12-31-$578M$153M-$731M
2014-03-31$624M$137M$487M
2013-12-31$1.25B$151M$1.09B
2013-03-31$1.19B$88M$1.1B
2012-12-31$941M$95M$846M
2012-03-31$1.59B$162M$1.43B

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$19.03B$1.21B$17.82B421.58%
2024-12-31$18.81B$974M$17.83B416.83%
2023-12-31$22.84B$777M$22.06B453.67%
2022-12-31$24.94B$695M$24.25B204.87%
2021-12-31$22.78B$787M$21.99B190.52%
2020-12-31$17.59B$798M$16.79B363.73%
2019-12-31$13.32B$552M$12.77B162.04%
2018-12-31$13.43B$638M$12.79B224.88%
2017-12-31$9.96B$529M$9.43B177.64%
2016-12-31$7.04B$479M$6.56B110.23%
2015-12-31$7.54B$532M$7B136.14%
2014-12-31$3.55B$612M$2.94B165.56%
2013-12-31$6.27B$491M$5.78B
2012-12-31$6.35B$333M$6.01B
2011-12-31$6.25B$356M$5.89B